---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-019022"
form_type: "8-K"
ticker: "LGVN"
cik: "0001721484"
company_name: "Longeveron Inc."
filed_at: "2023-03-10T23:59:59+00:00"
generated_at: "2026-06-18T05:37:42.404836+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Longeveron Q4 net loss $4.5M, FY 2022 loss $18.8M; cash $19.6M, runway into H1 2024

## Summary
- Q4 2022 net loss $4.5M ($0.21/share) vs $4.1M; full year loss $18.8M ($0.90/share) vs $17.0M.
- Revenue Q4 $0.1M, full year $1.2M (flat vs $1.3M); clinical trial revenue up 29% to $0.9M.
- Cash and short-term investments $19.6M at Dec 31, 2022, down from $35.0M; funds operations into H1 2024.
- Completed enrollment in Phase 2a Alzheimer's trial (CLEAR MIND, 48 patients); topline results expected early 2024.
- Initiated Phase 2 Aging-Related Frailty trial in Japan; first patient randomization expected Q1 2023.

## SEC filing metadata
- accession: 0001213900-23-019022
- form_type: 8-K
- ticker: LGVN
- cik: 0001721484
- company_name: Longeveron Inc.
- filed_at: 2023-03-10T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1721484/000121390023019022/0001213900-23-019022-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1721484/000121390023019022/ea175011-8k_longeveron.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-019022
- JSON: https://secwatch.observer/filing/0001213900-23-019022.json
- Plain text: https://secwatch.observer/filing/0001213900-23-019022.txt

## Key facts
- Earnings Releases
  Longeveron Inc. reported fourth quarter and full year of 2022 results: revenue Revenue in the fourth quarter 2022 was $0.1 million compared to $0.2 million in the same period in 2021. Revenue for ful, net income Net loss was $4.5 million in the fourth quarter of 2022 compared to $4.1 million for the same period in 2021. Net loss f.
  - Period: fourth quarter and full year of 2022
  - Revenue: Revenue in the fourth quarter 2022 was $0.1 million compared to $0.2 million in the same period in 2021. Revenue for ful
  - Net income: Net loss was $4.5 million in the fourth quarter of 2022 compared to $4.1 million for the same period in 2021. Net loss f
  - Result: reported results
  source text: On March 10, 2023, the Company announced financial and operating results as of and for the three and twelve months ended December 31, 2022 and 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1721484/000121390023019022/0001213900-23-019022-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.